Ultrasis PLC Trading statement (4512P)

TIDMULT

RNS Number : 4512P

Ultrasis PLC

19 August 2014

Ultrasis plc

("Ultrasis" or the "Company")

Trading statement

Ultrasis plc issues the following trading statement for the financial year ended 31 July 2014.

Strategy

The strategy for the Group is to grow the income base through increasing sales and acquisitions that contribute to our mission to be a provider of a complementary range of health and social care related services. During this year, the Group has completed three acquisitions and won several significant contracts, which are moving the Group towards profitability. As we deliver this strategy we are very pleased to have the loan facility from Mr Paul Bell in place, of which approximately GBP1 million remained undrawn at the year end.

Highlights

   --      Invoiced sales for the year will be approximately GBP2 million (2012/13: GBP0.7 million) 
   --      Staff team increased from 20 to over 50 and continues to grow

-- Secured a three year contract through Screenetics to deliver health assessments that has the potential to deliver over GBP2 million sales per annum

-- Secured a three year contract to provide on-line mental health support within 5 of the 14 Health Boards in Scotland

-- Continue to invest in the development of several key on-line products and released the 'My Health Coach' app in both apple and android platforms

Screenetics

Since joining the Group in October 2013, Screenetics has secured sizeable contracts which the board believe have the potential to deliver GBP10 million of new business over the next 3 years. These contracts are all based on performance and delivery criteria but we are confident of successful delivery.

Waterloo Health Clinic

This acquisition was completed in January 2014 and has been successfully integrated into the Group infrastructure. The Clinic team have ensured that the services provided to our customers have remained of a high quality throughout this transition. The clinic has made financially positive contributions since acquisition and is ready to accelerate its growth in the coming year.

e-health

We have made significant headway with the development of our on-line products and widened our offering by the acquisition of Step Success in October 2013. The IT development and support has been outsourced which has resulted in an acceleration of the updating of the products and expansion of the platforms that they are available on. We are currently working on the integration of all our on-line products into a single platform.

The partnership established with the NHS, Ki Group, has begun to ready itself to be a provider of services that will support people to get immediate and cost effective access to treatment via the NHS. We expect to see some significant opportunities delivered within the next six months that will help drive adoption of these services within the core NHS market.

Outlook

The Group has made significant progress in the last twelve months and is on target to continue its growth trajectory to month on month profitability in 2015. We believe that the positive momentum gained in recent months can be maintained and substantial growth can be achieved in the next financial year.

The Board is continuing to deliver its strategy and will look at further acquisition, partnership and client opportunities where we can add value. In our last Annual Report we stated our objectives were to implement the agreed strategy resulting in increased revenues, a return to profitability and increased shareholder value. These will continue to be our objectives for the future as we drive the business forward.

For all enquiries relating to Ultrasis please contact:

 
Ultrasis plc                 Tel: +44 (0) 20 7535 
                              2050 
John Smith, Chief Executive 
 
 
 
  finnCap Ltd                  Tel: +44 (0) 20 7220 
                               0500 
 
Geoff Nash/Simon Hicks

Notes to Editors:

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTEAXPPFFLLEFF

Ultrasis (LSE:ULT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024